0.10Open0.10Pre Close0 Volume11 Open Interest66.00Strike Price0.00Turnover83.28%IV13.75%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.0375Delta0.0127Gamma764.10Leverage Ratio-0.0594Theta-0.0003Rho-28.68Eff Leverage0.0063Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet